Immuron Operating Margin Over Time
IMRN Stock | USD 1.88 0.03 1.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Immuron Performance and Immuron Correlation. Immuron |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.88 | Quarterly Revenue Growth 1.086 | Return On Assets (0.17) | Return On Equity (0.43) |
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Profit Margin Analysis
Compare Immuron Ltd ADR and related stocks such as Tscan Therapeutics, VectivBio Holding, and In8bio Inc Operating Margin Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCRX | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (24.1779) | (4.7965) | (4.9232) | (4.44) | (4.66) |
INAB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PHIO | (134) | (134) | (134) | (52.5038) | (124) | (301) | (474) | (937) | (53.3623) | (428) | (428) | (428) | (428) | (492) | (517) |
IMMX | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0918 | 0.0826 | 0.0734 |
IPHA | (4.9346) | (0.6448) | (0.3263) | (0.224) | (22.0132) | (0.6016) | 0.1348 | (1.2253) | 0.0644 | (0.3922) | (0.2409) | (3.9486) | (0.2347) | (0.2441) | (0.26) |
ADXN | (4.4103) | (10.9702) | (223) | (158) | (21.0369) | (95.9764) | (181) | (6.4715) | (0.2357) | (5.3692) | (3.3888) | (5.317) | (14.4261) | (6.376) | (6.69) |
APM | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (26.9347) | (36.8676) | (21.8086) | (12.3631) | (17.7199) | (24.3947) | (25.61) |
DYAI | (0.903) | 0.1 | 0.1 | 0.0325 | (0.4252) | (11.5493) | (10.0445) | (9.397) | (5.8609) | (5.5218) | (6.2585) | (6.1267) | (3.4521) | (2.839) | (2.98) |
Immuron Ltd ADR and related stocks such as Tscan Therapeutics, VectivBio Holding, and In8bio Inc Operating Profit Margin description
My Equities
My Current Equities and Potential Positions
Immuron Ltd ADR | IMRN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Australia |
Exchange | NASDAQ Exchange |
USD 1.88
Check out Immuron Performance and Immuron Correlation. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Immuron technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.